Page last updated: 2024-08-23

danazol and Enlarged Spleen

danazol has been researched along with Enlarged Spleen in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biswal, N; Chandar, R; Chandrasekaran, V; Jagadisan, B; Kumar, D1
Johnson, KF1
Baudard, M; Bourgarit, A; Delmer, A; Legrand, O; Lévy, V; Rio, B; Zittoun, R1
Alvarez, A; Cervantes, F; Hernández-Boluda, JC; Montserrat, E; Nadal, E1

Reviews

1 review(s) available for danazol and Enlarged Spleen

ArticleYear
Hemophagocytic Lymphohistiocytosis in A Child With Very Severe Aplastic Anemia: Double Jeopardy Resulting in Fatality.
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:1

    Topics: Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Child; Danazol; Delayed Diagnosis; Diagnostic Errors; Disease Progression; Drug Resistance; Fatal Outcome; Febrile Neutropenia; Hepatomegaly; Humans; Immunosuppressive Agents; Iron Overload; Lymphohistiocytosis, Hemophagocytic; Male; Splenomegaly

2017

Other Studies

3 other study(ies) available for danazol and Enlarged Spleen

ArticleYear
Splenomegaly and an abnormal peripheral smear associated with the use of danazol: case report.
    American journal of obstetrics and gynecology, 1984, Jul-15, Volume: 149, Issue:6

    Topics: Abscess; Adult; Blood Cell Count; Danazol; Female; Humans; Ovarian Diseases; Pregnadienes; Splenomegaly

1984
Treatment of agnogenic myeloid metaplasia with danazol: a report of four cases.
    American journal of hematology, 1996, Volume: 53, Issue:4

    Topics: Aged; Aged, 80 and over; Anemia; Combined Modality Therapy; Danazol; Erythrocyte Transfusion; Female; Humans; Male; Middle Aged; Primary Myelofibrosis; Splenomegaly

1996
Danazol treatment of idiopathic myelofibrosis with severe anemia.
    Haematologica, 2000, Volume: 85, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Danazol; Drug Evaluation; Female; Humans; Male; Middle Aged; Platelet Count; Primary Myelofibrosis; Splenomegaly; Treatment Outcome

2000